Common use of Index of Other Defined Terms Clause in Contracts

Index of Other Defined Terms. In addition to the terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(b) “Board” Recitals “Change of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07

Index of Other Defined Terms. In addition to the those terms defined above, the following terms terms, in their capitalized forms, shall have the respective meanings given thereto in the sections indicated below: “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Assignment AgreementCancelable ESCT Common Share” 1.3(xii) “Delaware Corporate Law” Recitals “BDC ElectionEffective Time” 5.18(b1.2 “ESCT” Preamble “ESCT Audited Financial Statements” 3.9(a) “BoardESCT Benefit Plan” 3.22(a) “ESCT Common Stock” 1.3(xii) “ESCT Common Stock Exchange Ratio” 1.3(xii) “ESCT Common Stock Purchase Warrant” 1.3(xvi) “ESCT Convertible Debenture” 1.3(xiv) “ESCT Disclosure Schedule” Art. III Intro “ESCT Financial Statements” 3.9(a) “ESCT Foreign Plans” 3.22(r) “ESCT In-Bound Licenses” 3.19(b) “ESCT Intellectual Property” 3.19(e) “ESCT Internal Financial Statements” 3.9(a) “ESCT Lease” 3.18(c) “ESCT-Leased Real Property” 3.18(a) “ESCT Material Contracts” 3.20(b) “ESCT Minor Contracts” 3.20(e) “ESCT Option Plan” 1.3(xviii) “ESCT Out-Bound Licenses” 3.19(c) “ESCT-Owned Intellectual Property” 3.19(a) “ESCT-Owned Real Property” 3.18(a) “ESCT-Owned Software” 3.19(m)(i) “ESCT Pension Plan” 3.22(b) “ESCT Permits” 3.8 “ESCT Receivables” 3.10 “ESCT Registered Intellectual Property” 3.19(f) “ESCT Replacement Option” 1.3(xviii) “ESCT Stockholders” Recitals “Change of Recommendation NoticeESCT Stock Option” 7.03(c1.3(xviii) “Chosen CourtsExchange Agent” 12.08(a2.1(a) “CLO PartnersExchange Fund” 2.1(b) “FIND” Preamble “ClosingFIND Benefit Plan” 4.01 4.21(a) “Commitment LetterFIND Common Stock” Recitals “CompanyFIND Common Stock Purchase Warrant” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b1.3(xv) “Company Financial AdvisorFIND Convertible Debenture” 5.20 “Company SEC Documents” 5.07(a1.3(xiii) “Company SecuritiesFIND Disclosure Schedule” 5.05(bArt. IV Intro “FIND Foreign Plans” 4.21(r) “Company Stockholder ApprovalsFIND In-Bound Licenses” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a4.18(b) “End DateFIND Intellectual Property” 11.01(b4.18(e) “EntityFIND Lease” 6.07 “Expense Reimbursement” 11.03(c4.17(c) “FeeFIND-Sharing ArrangementsLeased Real Property” 5.26(e4.17(a) “GSC SubFIND Material Contracts” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d4.19(b) “Money Laundering LawsFIND Minor Contracts” 6.12 “No Vote Expense Reimbursement” 11.03(b4.19(e) “NYSE RulesFIND Out-Bound Licenses” 5.07(i4.18(c) “Preliminary Proxy StatementFIND-Owned Intellectual Property” 9.02(a4.18(a) “Proxy StatementFIND-Owned Real Property” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a4.17(a) “SaratogaFIND-Owned Software” Preamble “Saratoga Commitment Letter” 6.05(b4.18(m)(i) “Saratoga DirectorsFIND Pension Plan” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a4.21(b) “TaxFIND Permits” 5.16(o4.7 “FIND Preferred Stock” 4.4(a) “Tax ReturnFIND Receivables” 5.16(o4.9 “FIND Registered Intellectual Property” 4.18(f) “Tax Sharing AgreementFIND SEC Reports” 5.16(o4.8(a) “Tax AuthorityFIND Series MX Convertible Preferred Stock” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.071.3(xii)

Index of Other Defined Terms. In addition to the those terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: “Adverse Recommendation Change” 7.03(a) “Defined Term Section Page ”Agreement” Preamble “Assignment Preamble, 3 ”Closing Date” 2.6, 9 ”Closing” 2.6, 8 ”Commercialization Agreement” Recitals, 3 ”Consent and Release Agreement” Recitals “BDC Election4 ”Consent and Release Consideration” 5.18(b2.7(f) “Board9 ”Escrow Account” Recitals “Change of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Recitals, 3 ”Escrow Agreement” 2.02 “Loan RepaymentRecitals, 3 ”Grant” 2.03 “MakeRecitals, 4 ”Intel Parties” 11.13, 27 ”Intel” Recitals, 4 ”Merger Agreement” Recitals, 4 ”Xxxxx” Preamble, 3 ”MSD Patents” Recitals, 3 ”Newco Licenses” Recitals, 4 ”Operating Agreement” Recitals, 3 ”Patriot Indemnitees” 9.2, 20 ”Patriot License to Intel” Recitals, 4 ”Patriot Rights Holders” Recitals, 3 ”Patriot/TPL Indemnitees” 9.3, 20 ”Patriot” Preamble, 3 ”P-Whole PaymentNewco” 11.03(d) “Money Laundering LawsRecitals, 4 ”Proceedings” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “3.7, 11 ”Registration Rights Agreement” 2.02 “Replacement Administration AgreementRecitals, 3 ”Stipulated Final Judgment” Recitals “Replacement Advisory AgreementRecitals, 4 ”Termination Date” Recitals “Replacement Facility10.1, 22 ”T-Newco” 2.02 “Replacement LenderRecitals, 4 ”TPL Indemnitees” 2.02 “Replacement Management Agreements9.1, 19 ”TPL” Recitals “RepresentativesPreamble, 3 ”Trade Secrets Litigation” 7.03(a) “SaratogaRecitals, 4 ”Warrant” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Recitals, 3

Index of Other Defined Terms. In addition to the terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: “Adverse Recommendation Change” Section 7.03(a) “Adviser” Recitals “Agreement” Preamble “Assignment AgreementAmended Company Articles” Recitals Section 2.04(a) “Bankruptcy Exceptions” Section 5.02(a) “BDC Election” 5.18(bSection 5.15(b) “BoardBuyer” Recitals Preamble “Change of Recommendation NoticeBuyer Financial Advisor” 7.03(c) 6.14 “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals Section 12.08 “Company” Preamble “Company AdviserArticles” Section 2.04(a) “Company Board” Recitals “Company Board Recommendation” 5.02(bSection 5.02(a) “Company Financial AdvisorCommon Stock” 5.20 Recitals “Company Regulatory Approvals” Section 5.03 “Company SEC Documents” 5.07(aSection 5.06(b) “Company Securities” Section 5.05(b) “Company Stockholders” Recitals “Company Stockholder ApprovalsApproval” 7.02 Section 5.02(a) “Company Stockholder Meeting” 7.02 Recitals “Company Stockholder ProposalsProposal” Section 7.02 Confidential Information Section 9.08 “Definitive Proxy StatementContemplated Transactions” 9.02(aRecitals “Designated Person” Section 2.04(b) “End Direct Purchase Closing” Section 4.02 “Direct Purchase Closing Date” 11.01(bSection 4.02 “Direct Purchase Closing Notice” Section 2.02(b) “EntityDirect Purchase Period” 6.07 “Expense Reimbursement” 11.03(cSection 2.02(b) “Fee-Sharing ArrangementsDirect Stock Purchase” 5.26(eSection 2.02(a) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Existing Administration Agreement” Recitals “Replacement Existing Advisory Agreement” Recitals “Replacement FacilityInitial Closing” 2.02 Section 4.01 “Replacement LenderInitial Closing Date” 2.02 Section 4.01 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Interest Purchase Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Recitals

Index of Other Defined Terms. In addition to the those terms defined above, the following terms terms, in their capitalized forms, shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change2009 Plan” 7.03(a7.3(b) “Affiliate Agreement” 2.2(j) “Agreement” Preamble “Assignment Amended & Restated Voting Agreement” Recitals “BDC ElectionAuthorized Stock Increase Amendment” 5.18(b7.3(b) “BoardXxxxx Option Plan” 2.1(a)(vi) “Cancelable Common Share” 2.1(a)(i) “Cancelable Company Common Stock Purchase Warrant” 2.2(a) “Cancelable Company Convertible Debenture” 2.2(a) “Cancelable Company Series A Convertible Preferred Stock Purchase Warrant” 2.2(a) “Cancelable Securities” 2.2(a) “Cancelable Series A Convertible Preferred Share” 2.1(a)(ii) “Cancelable Series A Convertible Preferred Stock” 2.1(a)(ii) “Certificate of Merger” 1.1 “Closing” 1.2 “Closing Date” 1.2 “Code” Recitals “Change of Recommendation NoticeCommon Stock Purchase Warrant Exchange Agreement” 7.03(c7.3(d)(iii)(10) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company AdviserBenefit Plan” 4.21(a) “Company Certificate of Designations Amendment” 7.3(b) “Company Common Stock” 2.1(a)(i) “Company Common Stock Purchase Warrant” 2.1(a)(iv) “Company Convertible Debenture” 2.1(a)(iii) “Company Series A Convertible Preferred Purchase Warrant” 2.1(a)(v) “Company Disclosure Schedule” Art. IV Intro “Company Foreign Plans” 4.21(r) “Company In-Bound Licenses” 4.18(b) “Company Intellectual Property” 4.18(e) “Company Lease” 4.17(c) “Company-Leased Real Property” 4.17(a) “Company Material Contracts” 4.19(b) “Company Minor Contracts” 4.19(e) “Company Out-Bound Licenses” 4.18(c) “Company-Owned Intellectual Property” 4.18(a) “Company-Owned Real Property” 4.17(a) “Company-Owned Software” 4.18(m)(i) “Company Pension Plan” 4.21(b) “Company Permits” 4.7 “Company Principal Stockholder” Preamble “Company Proxy Statement” 7.3(b) “Company Receivables” 4.9 “Company Registered Intellectual Property” 4.18(f) “Company Series A Convertible Preferred Stock” 2.1(a)(ii) “Company Series A Convertible Preferred Stock Purchase Warrant” 2.1(a)(v) “Company Special Meeting” 7.3(b) “Company Stockholder” 2.1 “Company Stock Option” 2.1(a)(vi) “Constituent Corporations” 1.1 “Convertible Debt Securities Exchange Agreement” 7.3(d)(iii)(9) “Delaware Secretary of State” 1.2 “DGCL” Recitals “Company Board RecommendationDissentable Shares” 5.02(b2.3(a) “Company Financial AdvisorDissenting Holder” 5.20 “Company SEC Documents” 5.07(a2.3(a) “Company Dissenting Shares” 2.3(a) “Effective Time” 1.2 “Exchange Agent” 2.2(a) “Exchange Fund” 2.2(a) “Exchange Ratio” 2.1(a)(i) “Indemnified Parties” 7.15(b) “Listing Date” 2.2(i)1) “Merger” 1.1 “Merger Securities” 5.05(b2.2(a) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Merger Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License AgreementMerger Sub Common Stock” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d2.1(a)(vii) “Money Laundering LawsMerger Sub Preferred Stock” 6.12 “No Vote Expense Reimbursement” 11.03(b5.4(b) “NYSE RulesMost Recent Company Balance Sheet” 5.07(i4.8(a) “Preliminary Proxy Most Recent Company Cash Flow Statement” 9.02(a4.8(a) “Proxy Most Recent Company Financial Statements” 4.8(a) “Most Recent Company Income Statement” 5.09 4.8(a) “Registration Rights AgreementMost Recent Company Statement of Stockholders’ Equity” 2.02 4.8(a) “Replacement Administration Name Change Amendment” 7.3(b) “Original Merger Agreement” Recitals “Replacement Advisory AgreementParent” Preamble “Parent Common Stock” Recitals “Replacement FacilityParent Common Stock Purchase Warrants” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a2.2(a) “SaratogaParent Consent Actions” Preamble “Saratoga Commitment Letter” 6.05(b7.3(b) “Saratoga DirectorsParent Convertible Debt Securities” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a2.2(a) “TaxParent Disclosure Schedule” 5.16(oArt. V Intro “Parent Preferred Stock” 5.4(a) “Tax Return” 5.16(oParent Representatives 7.3(c) “Tax Sharing AgreementParent Stockholders” 5.16(o7.2 “Parent Stock-Split” 7.2 “Parent Stock-Split Amendment” 7.3(b) “Tax AuthorityParent SEC Reports” 5.16(o5.7(a) “Transfer RestrictionsParent Stockholder Holdback” 3.03 7.2 “Termination FeeParent Preexisting Stock Option” 11.03(a2.1(a)(vii) “Underlying Beneficial OwnerParent Preexisting Warrant” 6.072.1(a)(vii) “Parent Written Consent” 7.3(d)(iii)(2)

Index of Other Defined Terms. In addition to the terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: “Adverse Recommendation Change” Change 7.03(a) “Agreement” Preamble “Assignment Agreement” Agreement Recitals “ATP 7.01(c)(v) Balance Closing 2.03(b) Balance Purchase 2.03(a) Balance Share Price 2.03(a) Balance Shares 2.03(a) BDC Election” 5.18(bElection 5.17(b) “Board” Board Recitals “Change of Recommendation Notice” Notice 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Courts 11.08 Closing 4.01 Company Preamble “Closing” 4.01 “Commitment Letter” Company Administrator Recitals “Company” Preamble “Company Adviser” Advisor Recitals “Company Board Recommendation” Recommendation 5.02(b) “Company Financial Advisor” 5.20 “Advisor 5.19 Company SEC Documents” 5.07(a) “Company Securities” Securities 5.05(b) “Company Stockholder Approvals” Approval 7.02 “Company Stockholder Meeting” Meeting 7.02 “Company Stockholder Proposals” Proposal 7.02 “Definitive Proxy Statement” 9.02(aStatement 8.02(a) “D&O Insurance 8.06(c) End Date” 11.01(bDate 10.01(b)(i) “Entity” 6.07 “Entity 6.06 Expense Reimbursement” 11.03(cReimbursement 10.03(a) “Fee-Sharing Arrangements” 5.26(eIndemnification Agreements 8.06(a) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” Person 8.06(a) Investment 2.01 “Investor” Investment Shares 2.01 Investor Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” Laws 5.18 New Independent Directors 2.02 NASDAQ Rules 5.07(i) “OHA Preamble OHA Administrator Recitals OHA Advisor Recitals OHA Directors 2.02 Plan Shares 2.01 Preliminary Proxy Statement” 9.02(aStatement 8.02(a) “Proxy Statement” Statement 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Agreement Recitals “Replacement Advisory Agreement” Agreement Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Agreements Recitals “Representatives” Representatives 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(bSDAT 5.01 Stock Purchase Plan 2.01 Takeover Statute 5.20(a) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(oAgreements 5.15(g) “Tax Authority” 5.16(oTermination Fee 10.03(a) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Owner 6.06

Index of Other Defined Terms. In addition to the terms defined above, Each of the following terms shall have is defined on the respective meanings given thereto in the sections indicated belowpage set forth opposite such term: “Adverse Recommendation Change” 7.03(a338 Increased Tax Liability 54 Accounting Principles 17 Acquired Subsidiary IP 31 Acquired Subsidiary Licensed IP 31 Active Employees 49 Adjustment Escrow Amount 20 Agreement 1 Allocation 15 Antitrust Laws 48 assessments 30 Assumed Agreements 2 Assumed Employment Agreements 2 Assumed Liabilities 6 Assumed Real Property Leases 2 Assumption Approval 13 Avoidance Actions 5 Base Amount 16 Buyer 1 Buyer Adjustment Amount 20 Buyer Benefit Plans 51 Buyer Default Termination 21 Canadian Customer Data 62 Closing 23 Closing Date 23 Closing Date Schedule 17 Closing Payment 16 Closing Payroll Periods 50 COBRA 51 Contract Designation Liabilities 14 Cure Payments 13 CV Cap 6 Deposit 21 Determination Date 54 Dispute Notice 18 Divested Assets 6 DOC 47 Documentary Materials 2 Employment Commencement Date 49 Environmental Laws 35 Equity Interests 2 Escrow Account 21 Escrow Agent 21 Escrow Agreement 21 Estimated Indebtedness 17 Estimated Net Working Capital Amount 16 Exchange Act 27 Excluded Assets 4 Excluded Employees 50 Excluded Liabilities 8 FCPA 37 Final Calculations 19 FTC 47 Hazardous Materials 35 HSR Act 47 Inactive Employees 49 Indebtedness Schedule 17 IRS 28 Motions 56 Necessary Consents 13 Offeree 49 Owned Real Property 2 Parties 1 Party 1 PBGC 29 Post-Closing Credit Facility 66 Professional Services 8 Purchase Price 16 Purchased Assets 15 Real Property Leases 34 Restructuring Liabilities 68 Restructuring Transactions 68 Review Period 18 Sale Order 69 SEC 24 Section 338(g) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(b) “Board” Recitals “Change of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Election 54 Securities Act 27 Seller 1 Seller Adjustment Amount 21 Seller Financial Advisor” 5.20 “Company Statements 27 Seller Properties 35 Seller SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Reports 27 Selling Entities 1 Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Incentive Agreement 33 Termination Date 72 Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Taxes 52 Transferred Employees 49 Transferred Insurance Policies 61

Index of Other Defined Terms. In addition to the those terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Assignment AMD” Preamble “AMD Asset Purchase Agreement” 4.1(b) “AMD Asset Sale Promissory Note” 4.1(c) “AMD Assumed Liabilities” 2.2 “AMD Closing Date Contributed Assets” 2.1(a) “AMD Contributed Assets” 2.1(b) “AMD Contributed Contracts” 2.1(a) “AMD Contributed Leased Real Property” 5.6(a) “AMD Contributed Owned Real Property” 5.6(b) “AMD Contributed Permits” 5.9(a) “AMD Deductible” 10.8(a) “AMD Distribution Agreement” 4.1(b) “AMD Entities” 5.1 “AMD Employment Agreements” 5.11(a) “AMD-FASL Patent Cross-License Agreement” 4.1(b) “AMD Flash Memory Business” Recitals “BDC ElectionAMD Flash Memory Business Income Statements” 5.18(b5.24 “AMD Indemnitees” 10.4 “AMD Investments” Preamble “AMD Post-Closing Contributed Assets” 2.1(b) “BoardAMD Pre-Closing Contributed Assets” Recitals “Change of Recommendation NoticeAMD Pre-Closing Taxes” 7.03(c2.4 “AMD Promissory Note” 4.1(c) “Chosen CourtsAMD Services Agreement” 12.08(a4.1(b) “CLO PartnersAMD Site” Preamble 5.15(a) “AMD Technology Services Agreement” 4.1(b) “AMD Threshold” 10.8(a) “Applicable Interest Rate” 8.9(b) “Assumed Liabilities” 2.2 “Austin Title Policy” 7.6(b) “Claimant” 10.9(a) “Closing” 4.01 4.1(a) “Commitment LetterClosing Date” 4.1(a) “Confidentiality Agreement” 12.13(b) “Contribution Consideration” Article III “Fab 25 Deed” 4.1(b) “FASL/AMD Services Agreement 4.1(b) “FASL (Japan)” Recitals “CompanyFASL (Japan) Employee Pension Fund” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.078.9(b)

Index of Other Defined Terms. In addition to the terms defined above, Each of the following additional terms shall have the respective meanings given thereto is defined in the sections indicated belowSection set forth opposite such term, which is set forth in the schedule that begins on the following page: “Adverse Accounting Firm 5.10(e) Agreement Preamble Appraisal Shares 1.7 Certificate of Merger 1.3 Clearday Awards 1.7 Clearday Balance Sheet 3.1(e) Clearday Board of Directors Recitals Clearday Bylaws 3.1(a) Clearday Care Preferred Stock 1.4(d) Clearday Care 1.4(d) Clearday Charter 3.1(a) Clearday Collective Bargaining Agreements 3.1(m) Clearday Common Shares Recitals Clearday Common Stockholders Recitals Clearday Component 5.10(c) Clearday Development Expenditures 4.2(e) Clearday Disclosure Letter 3.1 Clearday Employee Benefit Plans 3.1(l) Clearday Percentage 5.10(c) Clearday Permits 3.1(i) Clearday Preferred Shares Recitals Clearday Preferred Stockholders Recitals Clearday Property 3.1(o) Clearday Share Certificate 2.2(a) Clearday Stockholder Action 3.1(d) Clearday Stockholder Approval 3.1(q) Clearday Preamble Closing Clearday Component 5.10(e) Closing Date 1.2 Closing Parent Component 5.10(e) Closing 1.2 Competing Transaction 5.4(c) Confidentiality Agreement 5.2(b) Convertible Right 3.1(c) Covered Parent SEC Disclosure 3.2 Delaware Department 1.3 DGCL 1.1(a) Effective Time 1.3 Encumbrances 3.1(o) Environmental Laws 3.1(n) ERISA 3.1(l) Exchange Act 3.1(e) Exchange Agent 2.1 Exchange Fund 2.1 Exchange Ratio 5.10(b) Fully Diluted Basis 5.10(c) GAAP 3.1(e) Indemnified Party 5.9(a) Joint Ventures 3.1(b) Letter of Transmittal 2.2(a) Liens 3.1(b) Merger Consideration 1.4(b) Merger Registration and Proxy Statement 3.2(d) Merger Recitals OZ LP Interests 3.1(c) OZ Partnership 3.1(c) Panel 6.1(e) Parent Balance Sheet 3.2(e) Parent Board of Directors Recitals Parent Bylaws 3.2(i) Parent Charter 3.2(i) Parent Common Stock Recitals Parent Component 5.10(c) Parent Disclosure Letter 3.2 Parent New Preferred Stock 1.5(b) Parent Percentage 5.10(c) Parent Permits 3.2(j) Parent Preferred Stock Recitals Parent SEC Documents 3.2(e) Parent Stockholder Approval 3.2(r) Parent Stockholder Meeting 3.2(d) Parent Preamble Permitted Expenditures 4.2(e) Purchaser Parties Preamble Recommendation Change” 7.03(a5.1(b) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(bSEC 3.1(e) “Board” Recitals “Change of Recommendation Notice” 7.03(cSecurities Act 3.1(e) “Chosen Courts” 12.08(aSuperior Competing Transaction 5.4(d) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(bTakeover Statute 3.1(t) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(aTermination Date 7.1(b) “Company Securities” 5.05(bVWAP MarketCap 5.10(c) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(aWaiver Agreements 5.8(b) “End Date” 11.01(bWarrants 1.4(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Wire Asset Disposition 5.14(b)

Index of Other Defined Terms. In addition to the terms Accession Acceptance 40 Advisory Board 7 Advisory Board Resignation Letter 7 Affiliate 13 Agreement 6 Arbitration Agreement 44 Ardian Entity 38 BGB 9 Business 6 Business Day 14 CCC Financial Statements 2 of Exhibit 8.9 Claim Notice 24 Clean Team Agreement 27 Clearance 11 Closing 14 Closing Actions 14 Closing Bank Repayment Amount 23 Closing Conditions 11 Closing Confirmation 15 Closing Date 14 Company 5 Company Books 35 Company’s Manager 7 Control 13 Controlling 13 Data Room 27 De Minimis Amount 30 Deductible 30 Disclosure Schedule 21 Disclosures 17 Due Diligence 22 Effective Date 9 Equity Bridge 20 Exempted Claims 30 Facilities Agreement 6 Fairly Disclosed 27 Finance Documents 6 Finance Parties 23 Finance Parties’ Bank Account 23 Financing Collateral 7,8 Fundamental Guarantees 17 Further Disclosures 26 General DR USB Stick 27 Governmental Authority 12 Group 6 Group Companies 6 Guaranteed Obligations 39 Guarantor 6 Guarantor’s Guarantees 33 Indemnified Person 35 Insurer 31 Interest 9 Key Employees 6 of Exhibit 8.9 Knowledge Bearer 21 Leakage 20 Leased Real Property 6 Liability Cap 31 Liability Exclusion 31 Long Stop Date 16 Manager Resignation Letter 7 Material Agreements 4 of Exhibit 8.9 Notified Leakage Amount 10 Parties 6 Permit 10 of Exhibit 8.9 Permitted Claims 36 Permitted Leakage 20 Pre-Effective Date Tax Period 1 of Exhibit 12 Pro Rata Share 30 Purchase Price 9 Purchaser 5 Purchaser Claim 24 Purchaser’s Guarantees 33 Purchaser’s Related Parties 35 Purchaser’s Representatives 22 Purple Data Xxxx 00 Xxxxxx XX USB Stick 27 Real Property Leases 6 Red Data Room 27 Red DR USB Stick 27 Scheduled Closing Date 14 Seller 1 5 Seller 2 5 Seller 3 5 Seller 4 5 Seller 5 5 Sellers 5 Sellers’ Bank Account 10 Sellers’ Covenants 23 Sellers’ Guarantee 17 Sellers’ Indemnification Claims 36 Sellers’ Knowledge 21 Sellers’ Representative 42 Share Capital 6 Share Transfer Instrument 8 Shareholder Loan 7 Shareholder Loan Receivable 8 Shareholder Loan Termination Agreement 9 Shareholders’ Matters 3 of Exhibit 8.9 Shareholders’ Resolution Company 8 Shareholders’ Resolution Triple C Holding GmbH 7 Shareholders’ Resolutions Group Companies 8 Sold Shares 6 Subsidiary 6 Subsidiary Equity Interests 19 Subsidies 11 of Exhibit 8.9 Substitute Purchaser as defined above, the following terms shall have the respective meanings given thereto in the sections indicated belowSection 19(e) Tax 1 of Exhibit 12 Tax Audit 1 of Exhibit 12 Tax Authority 1 of Exhibit 12 Tax Return 1 of Exhibit 12 Tax Warranties 1 of Exhibit 12 Third Party Claim 28 Time Limitations 29 Top Customers 10 Transaction 6 Unaudited CCC Financial Statements 2 of Exhibit 8.9 Unaudited Company Trial Balances 2 of Exhibit 8.9 USB Sticks 27 VVG 29 W&I Insurance 31 Waiver 36 [see attached.] [redacted][Description: “Adverse Recommendation Change” 7.03(acontent of Exhibit 1-B redacted.] [redacted][Description: content of Exhibit 2.1(c) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(bredacted.] [redacted][Description: content of Exhibit 2.1(d) “Board” Recitals “Change of Recommendation Notice” 7.03(credacted.] (a) “Chosen Courts” 12.08(aFACILITIES AGREEMENT EXHIBIT 2.2(b) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(bFINANCING COLLATERAL (a) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(aSHAREHOLDER LOAN EXHIBIT 2.4-1 ADVISORY BOARD RESIGNATION LETTER EXHIBIT 2.4-2 SHAREHOLDERS’ RESOLUTION TRIPLE C HOLDING GMBH EXHIBIT 2.5-1 MANAGER RESIGNATION LETTER EXHIBIT 2.5-2 SHAREHOLDERS RESOLUTION COMPANY EXHIBIT 2.5-3 SHAREHOLDERS RESOLUTION GROUP COMPANIES EXHIBIT 2.6 RELATED PARTY AGREEMENT EXHIBIT 3.1(b) “Company Securities” 5.05(bSHARE TRANSFER INSTRUMENT EXHIBIT 3.2(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(aSHAREHOLDER LOAN RECEIVABLE TRANSFER AGREEMENT EXHIBIT 3.2(c) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “FeeSHAREHOLDER LOAN TERMINATION AGREEMENT EXHIBIT 3.3 CERTAIN SELLERS’ CONSENT EXHIBIT 3.4-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 “Make1 CONSENT OF GENERAL MEETING OF THE COMPANY EXHIBIT 3.4-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.072 CONSENT OF BOARD RESOLUTIONS OF THE COMPANY EXHIBIT 5.2 SELLERS’ BANK ACCOUNT EXHIBIT 7.3 CLOSING CONFIRMATION